Insider Transactions in Q3 2024 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2024
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-7.24%
|
$17,592
$12.73 P/Share
|
|
Jul 15
2024
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,375
-19.84%
|
$91,375
$17.08 P/Share
|
|
Jul 15
2024
|
Scott T. Rottinghaus Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,375
+16.56%
|
$43,000
$8.99 P/Share
|
|
Jul 12
2024
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,271
-9.47%
|
$34,065
$15.04 P/Share
|
|
Jul 11
2024
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,299
-15.2%
|
$64,485
$15.07 P/Share
|